The Saba Lab is focused on applying state-of-the-art statistical methodology to the systems-level analysis of the high throughput data including genetic, genomic, and proteomic studies of complex traits. Our goal is to use the data to uncover the sequence of events that starts with DNA and ends in disease. When we know the sequence of events and all the players, we can design better drugs that can effectively treat the disease and limit the side effects. We use the breadth of data available to predict the sequences of events, so a clinician or researcher can design a better experiment that has a higher probability of
success and ultimately speed up the drug development process.